Navigation Links
Generex Announces Results of Annual Stockholders' Meeting
Date:6/10/2011

, and more than 295 million shares outstanding, the voter turnout here is nothing short of remarkable."  Mr. Fletcher continued, "I note that more than 80% of the shares voted were in favour of the reverse stock split.  This vote is an endorsement of the new Generex management team and Board of Directors, and provides a clear mandate to proceed with the development plan unveiled by the Company on March 30, 2011."

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).  The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  The Company's buccal insulin spray product, Generex Oral-lyn™ is in Phase III clinical trials at several sites around the world.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases.  Antigen Express has pioneered the use of specific CD4+ T helper stimulation in immunotherapy.  One of its platform technologies relies on inhibition of expression of the Ii protein.  Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T helper cells and prevents the further growth of cancer cells.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes
2. Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia
3. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
4. Generex Announces $3.0 Million Capital Investment
5. Generex Provides Additional Details for October 21st Live Video Webcast
6. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
7. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
8. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
9. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
10. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
11. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... The overall research objective was to ... and use. Most researchers outsource NGS technologies; however, ... within the next 12 months. Data accuracy and ... sequencing instruments. Disease-related research is the dominant use ... to surge, with half of the respondents planning ...
(Date:9/30/2014)... MA (PRWEB) September 30, 2014 ... (UC) and collaboration company is dedicated to supporting ... connectivity needs. Julie Power, a carrier ... to ensure collaboration solutions stays connected and productive ... to the increased movement of businesses to cloud ...
(Date:9/30/2014)... 30, 2014 UFP Technologies, a ... packaging has recently introduced a custom insulated shipping ... . The new insulated shipper solves the issue ... process. UFP Technologies’ BioShell is a universal storage ... storage, handling and shipping. The insulated shipper keeps ...
(Date:9/30/2014)... September 30, 2014 The ... IACRN), a non-profit organization based in Pittsburgh, Pennsylvania, ... and Safety (ACRES), a Massachusetts non-profit charitable ... alliance agreement, setting the stage for multiple collaborative ... clinical research quality and safety through specialized nursing ...
Breaking Biology Technology:Global Next-generation Sequencing Trends 2SoundConnect Expands Carrier Services Division 2UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 2UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 3IACRN and ACRES to Support Clinical Research Nurses 2IACRN and ACRES to Support Clinical Research Nurses 3
... Calif., Sept. 21 VaxGen,Inc. (Pink Sheets: VXGN) ... and Exchange Commission (SEC) its Quarterly Report on ... The report can be found at the link,titled ... VaxGen,s web site,at http://www.vaxgen.com . (Logo: ...
... for marketing, NEW YORK, Sept. 21 Small ... and education for the,small bone and joint sector of ... been cleared by the FDA for marketing in the ... implanted, degradable,spacers to four applications with two others planned ...
... Inc. (Nasdaq:,CEPH) today announced that it has submitted ... and Drug Administration (FDA) requesting approval of,TREANDA(R) (bendamustine ... leukemia (CLL). CLL is a slowly progressing blood ... cases diagnosed every year in,the United States, according ...
Cached Biology Technology:VaxGen Files First Quarter 2007 Financials 2Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 2Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 3Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 4Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis 5Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 2Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 4
(Date:9/30/2014)... 2014  Spectra Automation, a trusted supplier ... and power generation industries, announced today the ... an easy-to-use and cost-effective data collection, analysis ... laboratories. Most upstream process ... systems. Accessing and consolidating data from these ...
(Date:9/30/2014)... threats in today,s ocean. From overfishing and pollution ... ecosystems are disappearing at unprecedented rates around the ... surrounding the island of Moorea in French Polynesia ... coral guard-crabs. New research from the National Museum ... McKeon and the museum,s predoctoral fellow Jenna Moore ...
(Date:9/30/2014)... HEIGHTS, Ill. (September 30, 2014) People who suffer ... can do to control their asthma besides properly taking ... a new article in the Annals of Allergy, ... American College of Allergy, Asthma and Immunology (ACAAI), asthma ... examining their lifestyle. The woman described in the Annals ...
Breaking Biology News(10 mins):Spectra Automation Introduces RECONN Bioprocess Manager 2Smithsonian scientists discover coral's best defender against an army of sea stars 2Asthma symptoms kicking up? Check your exposure to air pollution 2
... bacteria to become resistant to antibiotics as well as ... January issue of Microbiology . The findings could ... is managed in hospital settings. Researchers from the ... adding increasing amounts of disinfectant to laboratory cultures of ...
... first time that insects, like mammals, use vision rather than ... high-speed video cameras technology the BBC uses to capture ... desert locusts stepping along the rungs of a miniature ladder. ... perform complex tasks, such as visually-guided limb control, usually associated ...
... study recently completed in the gulf coast of Alaska by ... disappears, the production and export of high- quality food from ... could have serious consequences for marine food webs. , The ... matter to the marine environment," was recently published in the ...
Cached Biology News:Disinfectants may promote growth of superbugs 2Ladder-walking locusts show big brains aren't always best 2Glacial watersheds may contribute to oceanic food web 2
TNM-FH Insect Medium 1 liter...
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
... PureLink PCR Purification Kits provide rapid ... enzymes, short-failed PCR products, and salts from ... bind/wash/elute procedure:, provides two Binding Buffer ... bp* , can be performed in either ...
Biology Products: